RenovoRx, Inc.
RNXT$30M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaMOUNTAIN VIEW
Drugs in Pipeline
11
Phase 3 Programs
3
Upcoming Catalysts
1
Next Catalyst
Jun 15, 2026
13wMarket Overview
Stock performance and key metrics
RNXT News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
Juvista (avotermin)
Cicatrix
Gemcitabine
Locally Advanced Pancreatic Cancer
estradiol (Zesteem)
Burn
Avotermin (Juvista)
Cicatrix
Intradermal avotermin
Cicatrix
Mannose-6-Phosphate (Juvidex)
Wound
Zesteem
Cicatrix
Avotermin (RN1001)
Cicatrix
Prevascar
Cicatrix
Juvidex
Cicatrix
Avotermin
Cicatrix
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Juvista (avotermin) | Phase 3 | Cicatrix | - | - |
Gemcitabine | Phase 3 | Locally Advanced Pancreatic Cancer | - | - |
estradiol (Zesteem) | Phase 3 | Burn | - | - |
Avotermin (Juvista) | Phase 2 | Cicatrix | - | - |
Intradermal avotermin | Phase 2 | Cicatrix | - | - |
Mannose-6-Phosphate (Juvidex) | Phase 2 | Wound | - | - |
Zesteem | Phase 2 | Cicatrix | - | - |
Avotermin (RN1001) | Phase 2 | Cicatrix | - | - |
Prevascar | Phase 2 | Cicatrix | - | - |
Juvidex | Phase 2 | Cicatrix | - | - |
Avotermin | Phase 2 | Cicatrix | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply